Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
作者信息
Miedema Michael D, Lopez Faye L, Blaha Michael J, Virani Salim S, Coresh Josef, Ballantyne Christie M, Folsom Aaron R
机构信息
Minneapolis Heart Institute, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.
Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis.
出版信息
JAMA Intern Med. 2015 Jan;175(1):138-40. doi: 10.1001/jamainternmed.2014.6288.
Abstract
摘要
相似文献
1
Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.根据新的胆固醇指南确定他汀类药物治疗的适用性以及美国一个老年队列中降低血脂水平药物的普遍使用情况：社区动脉粥样硬化风险研究队列
JAMA Intern Med. 2015 Jan;175(1):138-40. doi: 10.1001/jamainternmed.2014.6288.
2
American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).美国心脏病学会/美国心脏协会（ACC/AHA）降低动脉粥样硬化性心血管疾病风险的胆固醇治疗I类指南：基于西班牙裔社区健康研究/拉丁裔研究（HCHS/SOL）结果对美国西班牙裔/拉丁裔的影响
J Am Heart Assoc. 2017 May 11;6(5):e005045. doi: 10.1161/JAHA.116.005045.
3
Medicare-eligible patients diagnosed with atherosclerosis: patterns in statin therapy and lipid monitoring.符合医疗保险条件的动脉粥样硬化患者：他汀类药物治疗和血脂监测的模式。
Curr Med Res Opin. 2009 Jun;25(6):1403-11. doi: 10.1185/03007990902905658.
4
Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines.2014年英国一个真实世界高风险队列中降脂治疗模式的回顾性研究：与英国国家卫生与临床优化研究所（NICE）2014年血脂修饰指南的比较。
BMJ Open. 2017 Feb 17;7(2):e013255. doi: 10.1136/bmjopen-2016-013255.
5
Should you be taking a statin? A new guideline suggests that even adults with normal cholesterol numbers should be on the drug.你应该服用他汀类药物吗？一项新指南建议，即使胆固醇数值正常的成年人也应该服用这种药物。
Johns Hopkins Med Lett Health After 50. 2014 Fall;26(9):1-4.
6
Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year.2013 年胆固醇指南对动脉粥样硬化性心血管疾病或糖尿病患者降脂治疗模式的影响：1 年后。
J Manag Care Spec Pharm. 2016 Aug;22(8):901-8. doi: 10.18553/jmcp.2016.22.8.901.
7
Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.2013ACC/AHA 血胆固醇指南对动脉粥样硬化性心血管疾病患者他汀类药物治疗模式和低密度脂蛋白胆固醇的影响。
J Am Heart Assoc. 2017 Mar 17;6(3):e004909. doi: 10.1161/JAHA.116.004909.
8
Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).基于指南的他汀类药物/降脂治疗用于一级预防的适用性以及冠状动脉钙化和临床心血管事件的准确性：动脉粥样硬化多民族研究（MESA）
Clin Cardiol. 2017 Mar;40(3):163-169. doi: 10.1002/clc.22642. Epub 2016 Nov 12.
9
Antihyperlipidemic Medication Treatment Patterns and Statin Adherence Among Patients with ASCVD in a Managed Care Plan After Release of the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.在 2013 年美国心脏病学会/美国心脏协会发布的《关于治疗血液胆固醇的指南》发布后，在管理式医疗计划中，患有 ASCVD 的患者的降脂药物治疗模式和他汀类药物的依从性。
J Manag Care Spec Pharm. 2016 Aug;22(8):892-900. doi: 10.18553/jmcp.2016.22.8.892.
10
Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.根据2013年美国心脏病学会/美国心脏协会胆固醇指南，非传统风险标志物在不符合他汀类药物治疗条件的个体中的应用价值。
Circulation. 2015 Sep 8;132(10):916-22. doi: 10.1161/CIRCULATIONAHA.115.016846. Epub 2015 Jul 29.
引用本文的文献
1
Are statins making older persons weaker? A discontinuation study of muscular side effects.他汀类药物是否会使老年人更虚弱？肌肉副作用的停药研究。
Geroscience. 2024 Feb;46(1):853-865. doi: 10.1007/s11357-023-00817-2. Epub 2023 May 25.
2
Primary prevention statin therapy in older adults.老年人一级预防他汀治疗。
Curr Opin Cardiol. 2023 Jan 1;38(1):11-20. doi: 10.1097/HCO.0000000000001003. Epub 2022 Nov 2.
3
Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis.他汀类药物治疗基于老年患者心血管结局的疗效：标准荟萃分析和贝叶斯网络分析。
J Int Med Res. 2020 Jun;48(6):300060520926349. doi: 10.1177/0300060520926349.
4
Trends in prevalence of guideline-based use of lipid-lowering therapy in a large health system.大型医疗系统中基于指南的降脂治疗使用情况的流行趋势。
Clin Cardiol. 2020 Jun;43(6):560-567. doi: 10.1002/clc.23347. Epub 2020 Feb 27.
5
Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).根据 2016 年美国预防服务工作组（USPSTF）他汀类药物指南，他汀类药物的适用性、冠状动脉钙和随后的心血管事件：MESA（动脉粥样硬化多民族研究）。
J Am Heart Assoc. 2018 Jun 13;7(12):e008920. doi: 10.1161/JAHA.118.008920.
6
Cardiovascular Risk and Statin Eligibility of Young Adults After an MI: Partners YOUNG-MI Registry.年轻人心肌梗死后的心血管风险和他汀类药物适用性：Partners YOUNG-MI 注册研究。
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302. doi: 10.1016/j.jacc.2017.11.007. Epub 2017 Nov 12.
7
Statin Eligibility and Outpatient Care Prior to ST-Segment Elevation Myocardial Infarction.ST段抬高型心肌梗死之前的他汀类药物适用情况及门诊治疗
J Am Heart Assoc. 2017 Apr 12;6(4):e005333. doi: 10.1161/JAHA.116.005333.
8
Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.全美心脏病学实践中对 2013 年美国心脏病学会/美国心脏协会胆固醇管理指南的采用。
JAMA Cardiol. 2017 Apr 1;2(4):361-369. doi: 10.1001/jamacardio.2016.5922.
9
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines.2013年美国心脏病学会/美国心脏协会心血管疾病预防指南发布一年半后的心血管疾病预防前进之路
Mayo Clin Proc. 2015 Sep;90(9):1262-71. doi: 10.1016/j.mayocp.2015.05.018. Epub 2015 Aug 11.
10
Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis.他汀类药物用于老年患者心血管疾病的一级预防：系统评价与荟萃分析。
Drugs Aging. 2015 Aug;32(8):649-61. doi: 10.1007/s40266-015-0290-9.
本文引用的文献
1
Application of new cholesterol guidelines to a population-based sample.新胆固醇指南在基于人群样本中的应用。
N Engl J Med. 2014 Apr 10;370(15):1422-31. doi: 10.1056/NEJMoa1315665. Epub 2014 Mar 19.
2
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12.
3
4
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins.美国心脏病学会/美国心脏协会/美国国立心肺血液研究所关于他汀类药物使用与安全性的临床咨询意见。
Circulation. 2002 Aug 20;106(8):1024-8. doi: 10.1161/01.cir.0000032466.44170.44.
5
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.社区动脉粥样硬化风险（ARIC）研究：设计与目标。ARIC研究团队
Am J Epidemiol. 1989 Apr;129(4):687-702.
Zotero 插件